Metraipolis › archive › dc_4df3aa0cfecb

Plasma P-tau217, GFAP, and NfL as biomarkers for Alzheimer's disease: role in disease stratification, pathological progression, and cognitive decline — Europe PMC PMID:41376134

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41376134
DOI: 10.1002/alz.70987
License (as archived): solo-consultazione
Archived: 2026-11-08T01:56:50.352Z
SHA-256 of the archived text: 727683b4eb50731a5502621ba25343def4495761f8a5b3b535cf43f375bfb7f9
Stable URL of this page: https://metraipolis.com/documento/dc_4df3aa0cfecb

How to cite

Plasma P-tau217, GFAP, and NfL as biomarkers for Alzheimer's disease: role in disease stratification, pathological progression, and cognitive decline — Europe PMC PMID:41376134 — Europe PMC (en), https://europepmc.org/article/MED/41376134 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4df3aa0cfecb (Metraipolis archive dc_4df3aa0cfecb, sha256 727683b4eb50731a5502621ba25343def4495761f8a5b3b535cf43f375bfb7f9)

BibTeX

@misc{dc4df3aa0cfecb,
  title = {Plasma P-tau217, GFAP, and NfL as biomarkers for Alzheimer's disease: role in disease stratification, pathological progression, and cognitive decline — Europe PMC PMID:41376134},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41376134},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4df3aa0cfecb; sha256 727683b4eb50731a5502621ba25343def4495761f8a5b3b535cf43f375bfb7f9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41376134. Agents can read the archived copy with the MCP tool read_document.